Sarcoma of the uterus

Sarcoma of the uterus body is a rare malignant tumor, which occurs only in three to five percent of cases of all cancer of the body. This disease is characterized by a high degree of metastasis and recurrence. Most of all, this dangerous disease affects women during the postmenopausal period.

Symptoms

At the initial stage, the symptoms of uterine sarcoma are very slight. Usually, the doctor should be consulted several months after the disease began to develop. The woman notices that the whitewash becomes watery, an unpleasant smell appears, sometimes a discharge of blood appears in the secretions. The menstrual cycle is usually broken, and the lower abdomen constantly hurts. Late stages are characterized by weakness, poor appetite, weight loss, the appearance of anemia, which is not associated with bleeding. If the uterus sarcoma has metastasized into the liver, lungs or other organs, then a number of symptoms appear that are characteristic of the lesion of a particular organ.

Symptoms of uterine sarcoma are similar to those of diseases such as uterine fibroids , ovarian tumor, endometrial polyps , and tumors of uterus adjacent to the uterus. This oncological disease also often resembles a uterine pregnancy.

The reasons that provoke the development of uterus sarcoma or cervix are still unknown to science. However, women who had the first menstruation late, and those who gave birth after the age of 35, had miscarriages, abortions, fibroids, are at risk.

Diagnostic Methods

The first thing that a woman needs to do is consult a gynecologist and an oncogynecologist. If suspicions are confirmed, a number of laboratory methods of investigation will be needed. These include histological studies, in which the scraping of the endometrium or a tumor removed during surgery is studied, as well as immunohistochemical studies to determine the type of sarcoma. If necessary, the doctor will conduct a hysteroscopy, that is, examine the hysteroscope of the uterine cavity wall, hysterocervicalography, computed tomography, MRI, sounding, ultrasound tomography with Doppler color mapping, as well as lung radiography and liver scans to help identify distant metastases.

Treatment

Treatment of uterine sarcoma by methods such as drug and radiation therapy, surgical intervention is very important, not less than twice a year to visit a gynecologist. In this case, the disease will be detected at an early stage, which significantly increases the chances of a successful cure.

Sarcoma - a tumor is extremely aggressive. It easily sprouts into nearby organs, quickly releases metastases, spreading through the lymphatic and circulatory system, affecting lymph nodes, bones, liver and lungs.

The most favorable prognosis for patients with uterine endometrial stromal sarcoma is that 57% of women live five years or more. A similar survival rate for women diagnosed with leiomyosarcoma is 48%. The least favorable prognosis for patients with carcinosarcoma is no more than 27%, as well as those diagnosed with endometrial sarcoma. Relatively favorable course is typical for uterine sarcoma, which develops from the fibromatous node, if there are no metastases.

If the endocrine disorders are diagnosed and corrected in a timely manner, endometritis, uterine fibroids, endometriosis and endometrial polyps are treated, the likelihood of oncological diseases is significantly reduced. Preventive measures are also the correct selection of contraceptives and the prevention of abortions.